NUVL
Price:
$123.43
Market Cap:
$9.08B
Nuvalent, Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering novel therapeutic solutions for individuals battling cancer. The company's pipeline features two prominent drug candidates. One of these is NVL-520, a highly selective ROS1 inhibitor capable of penetrating the brain. This compound is specifically designed to target ROS1 fusions that possess the normal ROS1 kinase domain, and crucially, it retains activity against mutations known to confer resistance to both approved and experimental ROS1 inhibitors. NVL-520 is currently undergoing Phase I clinical evaluation. Nuvalent's second key asset is NVL-655, an ALK-selective inhibitor that also exhibits brain-penetrant p...[Read more]
Industry
Biotechnology
IPO Date
2021-07-29
Stock Exchange
NASDAQ
Ticker
NUVL
According to Nuvalent, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 8.92B. This represents a change of 33.78% compared to the average of 6.67B of the last 4 quarters.
The mean historical Enterprise Value of Nuvalent, Inc. over the last ten years is 2.71B. The current 8.92B Enterprise Value has changed 32.83% with respect to the historical average. Over the past ten years (40 quarters), NUVL's Enterprise Value was at its highest in in the March 2026 quarter at 7.90B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.
Average
2.71B
Median
1.24B
Minimum
346.22M
Maximum
7.05B
Discovering the peaks and valleys of Nuvalent, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 257.38%
Maximum Annual Enterprise Value = 7.05B
Minimum Annual Increase = -53.50%
Minimum Annual Enterprise Value = 346.22M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 7.05B | 39.52% |
| 2024 | 5.05B | 27.94% |
| 2023 | 3.95B | 219.17% |
| 2022 | 1.24B | 257.38% |
| 2021 | 346.22M | -17.68% |
| 2020 | 420.60M | -53.50% |
The current Enterprise Value of Nuvalent, Inc. (NUVL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
5.35B
5-year avg
3.53B
10-year avg
2.71B
Nuvalent, Inc.’s Enterprise Value is less than Axsome Therapeutics, Inc. (12.81B), greater than Merus N.V. (6.52B), less than Cytokinetics, Incorporated (10.96B), greater than Metsera, Inc. (6.98B), greater than Abivax S.A. (6.31B), greater than CRISPR Therapeutics AG (5.58B), greater than Vaxcyte, Inc. (7.28B), greater than Rhythm Pharmaceuticals, Inc. (6.80B), less than Jazz Pharmaceuticals plc (17.69B), less than Arrowhead Pharmaceuticals, Inc. (12.71B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 12.81B | $12.89B | |
| 6.52B | $6.83B | |
| 10.96B | $9.80B | |
| 6.98B | $7.43B | |
| 6.31B | $6.50B | |
| 5.58B | $5.22B | |
| 7.28B | $7.43B | |
| 6.80B | $6.64B | |
| 17.69B | $14.11B | |
| 12.71B | $11.52B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nuvalent, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nuvalent, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Nuvalent, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Nuvalent, Inc. (NUVL)?
What is the 3-year average Enterprise Value for Nuvalent, Inc. (NUVL)?
What is the 5-year average Enterprise Value for Nuvalent, Inc. (NUVL)?
How does the current Enterprise Value for Nuvalent, Inc. (NUVL) compare to its historical average?